Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple ...

Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

Qiagen has entered into a commercial collaboration with ID Solutions for digital polymerase chain reaction (dPCR) assays.

Guardant Health has a trailing 12 month Price to Earnings (P/E) ratio of -13.4 while the S&P 500 average is 29.3 Its forward ...

Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to ...

Further assay results have been released by PTX Metals (TSXV: PTX) related to a phase 1 drill program conducted at their W2 ...

Nova Pacific Metals Corp. (CSE: NVPC) (OTCQB: NVPCF) (FSE: YQ10) (WKN: A40GFH) (the "Company", or "Nova Pacific") is pleased ...

Hayasa has contracted AT Group , a drilling company based in Yerevan, Armenia which has worked with the Company in the past.

A new study shows how person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.

Qiagen N.V. (NYSE: QGEN) has announced two strategic partnerships designed to revolutionize minimal residual disease (MRD) ...